David Dunbar
Analyst · CJS Securities
Thank you, Chris. Good morning, and welcome to our fiscal third quarter 2026 conference call. This quarter provides another strong proof point that our strategy, shifting to our faster-growing end markets and increasing new product development is working. We delivered top line sales growth of 8%, including organic growth of 6.5%. Our sales in the fast-growing end markets are now about 30% of our total, and new products are expected to add 300 basis points of growth to our 2026 sales results. It is also exciting to see how the mix of our businesses has evolved. Today, Electronics and our Engineering Technologies business generate about 70% of sales and nearly 80% of total segment profits, both built around custom-engineered solutions for attractive secular markets. That mix shift is what we set out to achieve. Our Engineering Technologies segment has effectively repositioned itself as a vital partner for space, defense and aviation customers. So we are renaming the segment Standex Aerospace & Defense. Looking ahead, demand remains healthy. Company-wide book-to-bill was 1.05 and Electronics delivered 1.14, setting us up well as we move into the fourth quarter. I would like to thank our employees, our executives and the Board of Directors for their efforts and continued dedication and support that drove our solid fiscal third quarter 2026 results. Now let's look at the results beginning on Slide 3. In the third quarter, sales increased 8.1% year-on-year to $224.6 million, including 6.5% organic growth. Electronics grew 6.8% organically. New product sales grew approximately 40% to approximately $18.7 million. Sales in the fast-growth markets were approximately $69 million, more than 30% of total sales. We are pleased with the momentum in the business reflected in an overall book-to-bill ratio of 1.05 and within Electronics of 1.14. Adjusted operating margin of 19.7%, was up 30 basis points year-on-year. On March 6, we completed the divestiture of Federal Industries at an enterprise value of approximately $70 million. This is in line with our Portfolio Simplification strategy, allowing us to focus our management and capital resources more on fast growth markets and new product launches. We used the proceeds to pay down about $62 million of debt, reducing net leverage to 1.9x. Beginning this quarter, we will report under four operating segments: Electronics, Aerospace & Defense, Scientific and Engraving & Hydraulics. The Hydraulics business has been combined with the Engraving business under the Engraving & Hydraulics segment. This divestiture continues a decade of deliberate portfolio shaping toward higher growth, higher-margin businesses. In 2014, we operated 16 businesses. Today, we're down to 5. And following the Amran/Narayan acquisition, Electronics represents more than half of Standex, helping drive the performance you see today. Our original fiscal year 2026 sales outlook included a full year contribution from Federal Industries. Even after the Federal divestiture, we still expect fiscal 2026 revenue to increase by about $100 million versus 2025, supported by momentum in new products and fast growth markets, especially in Electronics and Aerospace & Defense. I'm pleased with the momentum that we are building and launching new products. We expect to launch more than 15 new products this fiscal year on top of 16 new products last fiscal year. We expect new product sales pro forma for the Federal divestiture to grow by $24 million to $64 million, adding nearly 300 basis points of organic growth in the year. Our sales into the fast-growing markets such as Space, Defense and Grid, are expected to increase to approximately $270 million, constituting about 30% of our total sales. On a sequential basis, we expect slightly higher revenue driven by higher contributions from fast growth end markets and new product sales and slightly to moderately higher adjusted operating margin due to higher volume and pricing and productivity initiatives, partially offset by growth investments. On a year-on-year basis, in fiscal fourth quarter 2026, we expect slightly to moderately higher revenue, driven by mid- to high single-digit organic growth from growing backlog in fast-growth markets and increased new product sales, partially offset by the revenue impact from the Federal divestiture. We expect slightly lower adjusted operating margin as organic growth and realization of productivity actions are more than offset by growth investments in capacity expansions, higher medical costs and increased variable compensation expenses. I will now turn the call over to Ademir to discuss our financial performance in greater detail.